PeterNWeissmanMD

Endocrinology • Miami, FL

Diabetes, Lipid Metabolism

Associate Clinical Professor of Medicine, University Miami School of Medicine

Join to view full profile

Dr. Weissman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Weissman's full profile

Already have an account?

Office
7867 N Kendall Dr
Suite 80
Miami, FL 33156
Phone+1 305-595-0777

Fax+1 305-412-9255
Is this information wrong?

Education & Training

University of Michigan Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1970 - 1972
University of Michigan Health SystemResidency, Internal Medicine, 1970 - 1972
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1967 - 1968
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1966 - 1967
New York University School of MedicineClass of 1966

Certifications & Licensure

MI State Medical License Current
FL State Medical License 1973 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:South Florida Castle Connolly, 2012
SouthFloridaCEO: Top Doctors Castle Connolly, 2002-2003
Miami Metro City Guide: Top Doctors Castle Connolly, 2001
Top Doctors: Florida Castle Connolly, 2000
Fellow (FACE) American Association of Clinical Endocrinology
Top MD Consumers Checkbook
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Start of enrollment: 2011 Mar 01
Terminated
Phase 3
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3

Publications & Presentations

PubMed

14 citations
Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy
Philip Home, Bo Ahrén, Jane E.B. Reusch, Marc Rendell, Peter N. Weissman, Deborah T. Cirkel, Diane Miller, Philip D. Ambery, Molly C. Carr, Michael A. Nauck> ;Diabetes Research and Clinical Practice. 2017 Sep 1
102 citations
HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin wit...
Peter N. Weissman, Molly C. Carr, June Ye, Deborah T. Cirkel, Murray Stewart, Caroline R Perry, Richard E. Pratley> ;Diabetologia. 2014 Sep 11
5 citations
Clinical practice effect of rosiglitazone discontinuation on glycemic control.
Etta L. Fanning, Peter N Weissman, Laura Menditto> ;Endocrine Practice. 2009 Apr 1
15 citations
Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial su...
Barry J. Goldstein, Peter N Weissman, Margaret Wooddell, Brian Waterhouse, Alexander R. Cobitz> ;Current Medical Research and Opinion. 2006 Sep 1
58 citations
Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study.
Peter N Weissman, Barry J. Goldstein, J Rosenstock, Brian Waterhouse, Alexander R. Cobitz, Margaret Wooddell, L J Strow> ;Current Medical Research and Opinion. 2005 Nov 4
5 citations
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus
Peter N Weissman> ;The American Journal of Cardiology. 2002 Sep 5
25 citations
Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients
Valerie M. Donaghue, John M. Giurini, Barry I. Rosenblum, Peter N. Weissman, Aristidis Veves> ;Diabetes Research and Clinical Practice. 1995 Jul 1
A search for macroangiopathy in patients with latent diabetes.
Peter N. Weissman, Park W. Willis, John C. Floyd, Sumer Pek, Jerome W. Conn> ;Advances in Metabolic Disorders. 1973 Jan 1
14 citations
Basement membrane thickening in latent diabetes.
Joseph R. Williamson, P Weissman, N J Bogler, Charles Kilo, Jerome W. Conn> ;Advances in Metabolic Disorders. 1973 Jan 1
21 citations
Amino acids and insulin release in vivo.
John C. Floyd, Sumer Pek, Jerome W. Conn, , > ;Israel Journal of Medical Sciences. 1972 Mar 1
4 citations
Adrenergic effects which modify arginine-induced insulin release in man.
Jr Jc Floyd, Sumer Pek, Jerome W. Conn, , > ;The Journal of Laboratory and Clinical Medicine. 1971 Dec 1
4 citations
Adrenergic effects which modify arginine-induced insulin release in man.
Jr Jc Floyd, Sumer Pek, Jerome W. Conn, , > ;The Journal of Laboratory and Clinical Medicine. 1971 Dec 1
Join now to see all

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Fellow

Hospital Affiliations

Baptist Hospital of MiamiMiami, Florida
South Miami HospitalMiami, Florida